Influence of Autologous Blood Transfusion on Natural Killer and Lymphokine‐Activated Killer Cell Activities in Cancer Surgery
- 1 November 1997
- journal article
- clinical trial
- Published by Wiley in Vox Sanguinis
- Vol. 73 (4) , 237-245
- https://doi.org/10.1046/j.1423-0410.1997.7340237.x
Abstract
Background and objectives: Immunosuppression associated with blood transfusion may influence postoperative infection rates. It may also affect the prognosis of patients treated surgically for colorectal cancer. To control this effect, study protocols have applied autologous blood donation programs, which are thought to be immunologically neutral. However, evidence has emerged that blood donation itself might have suppressive effects on natural killer (NK) cell activities. At present, there are no data available on the effects of autologous blood transfusion on NK or lymphokine‐activated killer (LAK) cells. This might be of interest as LAK cells may be active in tumor control. Materials and methods: 26 patients who underwent surgical resection for colorectal cancer, were assigned at random into two groups: (1) autologous blood donation and transfusion, or (2) allogeneic blood transfusion. NK and LAK activities were determined before blood donation, at surgery, and on the 3rd and 8th postoperative day. Results: Blood donation induced a small decrease in NK and LAK activities. The postoperative courses of the two groups differed. In the allogeneic group, NK activity (−50%, p = 0.018) and LAK activity decreased (−60.7%, p = 0.043), whereas in the autologous group the decline in LAK was less pronounced (−33.7%, p = 0.091), and their NK activity even increased (+17.4%, p = 0.315). NK activity was modulated differently in the two study groups (0.0036). Differences in LAK activities were found between the 3rd and 8th day postoperatively (p = 0.354). Conclusions: In patients receiving autologous blood transfusion, postoperative suppressed NK and LAK activities were modulated. This implies that autologous blood transfusion is not immunologically neutral, but has an intrinsic immunomodulatory potential.Keywords
This publication has 34 references indexed in Scilit:
- Perioperative Blood Transfusions and Prognosis in Patients with Curatively Resected Locally Advanced Gastric CancerOncology, 1995
- Allogeneic blood transfusion reduces murine pulmonary natural killer (NK) activity and enhances lung metastasis of a syngeneic tumourInternational Journal of Cancer, 1993
- Beneficial effect of autologous blood transfusion on infectious complications after colorectal cancer surgeryThe Lancet, 1993
- Kinetic Analysis of Lymphokine‐Activated Killer (LAK) Cells: Lytic Parameters and Determination of LAK Cell FrequencyScandinavian Journal of Immunology, 1989
- Antibacterial activity of human natural killer cells.The Journal of Experimental Medicine, 1989
- The Development of New Immunotherapies for the Treatment of Cancer Using Interleukin-2Annals of Surgery, 1988
- EFFECT OF BLOOD TRANSFUSIONS ON COLONIC MALIGNANCY RECURRENCE RATEThe Lancet, 1982
- Natural Killer Cells: Their Roles in Defenses Against DiseaseScience, 1981
- Blood transfusion-induced suppression of cellular immunity in manHuman Immunology, 1980
- Improvement of Kidney-Graft Survival with Increased Numbers of Blood TransfusionsNew England Journal of Medicine, 1978